MSK Report News

Thursday, December 03, 2009 Weekly Roundup: In the News This Week
Read what MSKreport has been tweeting about this week...

Wednesday, December 02, 2009 BioPharm Business News and Perspectives: OxyPharma's New RA Drug Shows Positive Phase II Results
Rabeximod, an orally-administered DMARD, showed promise as a new RA treatment during a 16-week study...

Tuesday, November 24, 2009 Arthritis: Fatigue Is Valid Marker of RA Treatment Response
Single-item measures of fatigue are reliable and sensitive to change in RA patients taking TNF-blockers...

Thursday, November 19, 2009 BioPharm Business News and Perspectives: French Government Buys Into Naproxinod
NicOx has submitted an NDA for naproxinod for osteoarthritis, and is raising $149 million for the launch...

Wednesday, November 18, 2009 BioPharm Business News and Perspectives: FDA Wants Pain Pump Label Warnings
Chondrolysis follows continuous intra-articular local anesthetic infusion, FDA says...

Tuesday, November 17, 2009 Arthritis: Inflammation in RA Linked to Arterial Stiffness
RA patients with high inflammatory burden are more likely to have arterial stiffness, even without other known cardiovascular risk factors...

Thursday, November 12, 2009 BioPharm Business News and Perspectives: Bristol Set to Challenge Roche for RA IL-6 Blockers
Bristol-Myers Squibb has licensed RA indications for Alder's ALD518 anti-IL-6 monoclonal...

Thursday, November 12, 2009 Arthritis: TNF Inhibitors Do Not Raise Cancer Risk
No increased cancer risk was seen during the first 6 years of anti-TNF therapy for rheumatoid arthritis...

Wednesday, November 11, 2009 Imaging: Cooling RA Skin May Slightly Shift Doppler US
Cooling (but not warming) the skin has a modest effect on ultrasound Doppler measurements in RA...

Thursday, November 05, 2009 Bones: TNFα Weakens Bones in Diabetes
High levels of TNF-α in diabetics accelerates cartilage loss, weakens bones, and slows fracture healing...